Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
暂无分享,去创建一个
Keith A. Johnson | R. Sperling | A. Schultz | C. Masters | S. Sikkes | D. Rentz | S. Burnham | K. Papp | R. Amariglio | E. Mormino | V. Villemagne | M. Properzi | R. Buckley | J. Rabin | V. Doré
[1] Keith A. Johnson,et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts , 2018, Alzheimer's & Dementia.
[2] Sterling C. Johnson,et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau , 2018, JAMA neurology.
[3] C. Jack,et al. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting , 2018, JAMA neurology.
[4] B. Snitz,et al. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting , 2018, Alzheimer's & Dementia.
[5] C. Jack,et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.
[6] Keith A. Johnson,et al. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global &bgr;-Amyloid Burden , 2017, JAMA neurology.
[7] W. Jagust,et al. Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly , 2017, Neurology.
[8] M. D. de Leon,et al. Sex differences in Alzheimer risk , 2017, Neurology.
[9] Reisa A. Sperling,et al. Harvard Aging Brain Study: Dataset and accessibility , 2017, NeuroImage.
[10] Michael Wagner,et al. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment. , 2017, Journal of Alzheimer's disease : JAD.
[11] F. Pasquier,et al. Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging , 2016, Alzheimer's & dementia.
[12] Colin L. Masters,et al. A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease , 2016, Journal of Molecular Neuroscience.
[13] W. M. van der Flier,et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. , 2015, Journal of Alzheimer's disease : JAD.
[14] Renaud La Joiea,et al. Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and b -amyloid imaging , 2016 .
[15] W. M. van der Flier,et al. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. , 2015, Journal of Alzheimer's disease : JAD.
[16] J. Becker,et al. Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study. , 2015, Journal of Alzheimer's disease : JAD.
[17] Oscar L Lopez,et al. Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[18] D. Y. Lee,et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. , 2015, JAMA.
[19] Matthew L Senjem,et al. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. , 2015, JAMA neurology.
[20] C. Hertzog,et al. Correlates and Moderators of Change in Subjective Memory and Memory Performance: Findings from the Health and Retirement Study , 2015, Gerontology.
[21] C. Rowe,et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. , 2015, Neuropsychology.
[22] Keith A. Johnson,et al. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.
[23] Andrew J. Saykin,et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.
[24] Rebecca A Betensky,et al. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease , 2014, Neurology.
[25] J. Karlawish,et al. The A4 Study: Stopping AD Before Symptoms Begin? , 2014, Science Translational Medicine.
[26] Owen Carmichael,et al. Everyday Cognition in Older Adults: Associations with Neuropsychological Performance and Structural Brain Imaging , 2013, Journal of the International Neuropsychological Society.
[27] Matthew L Senjem,et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly , 2012, Neurology.
[28] Reisa A. Sperling,et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals , 2012, Neuropsychologia.
[29] M. Mintun,et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline , 2012, Annals of neurology.
[30] G. Small,et al. Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia , 2012, International Psychogeriatrics.
[31] Elizabeth C Mormino,et al. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. , 2012, Archives of neurology.
[32] R. Sperling,et al. Specific Subjective Memory Complaints in Older Persons May Indicate Poor Cognitive Function , 2011, Journal of the American Geriatrics Society.
[33] C. Rowe,et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.
[34] J. Morris,et al. Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans , 2010, Alzheimer's & Dementia.
[35] C. Rowe,et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.
[36] Kathleen Baynes,et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. , 2008, Neuropsychology.
[37] Mony J. de Leon,et al. Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints , 2008, Biological Psychiatry.
[38] K. Blennow,et al. Cerebrospinal Fluid Biomarkers Predict Decline in Subjective Cognitive Function over 3 Years in Healthy Elderly , 2007, Dementia and Geriatric Cognitive Disorders.
[39] C. Jonker,et al. Are memory complaints predictive for dementia? A review of clinical and population‐based studies , 2000, International journal of geriatric psychiatry.
[40] Deborah Blacker,et al. Development and Validation of a Structured Telephone Interview for Dementia Assessment (STIDA): The NIMH Genetics Initiative , 1997, Journal of geriatric psychiatry and neurology.